Sin-Ho Jung

Conference Journal of Clinical Oncology · June 1, 2026 2619Background: Immunotherapy resistance remains a significant unmet clinical need for most non-small cell lung cancer (NSCLC) patients. PCSK9 was shown in preclinical models to mediate cancer immunotherapy resistance and may serve as a novel immuno-inhibi ... Full text Cite

Early myopathology of Pompe disease in patients detected by newborn screening

Conference JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY · June 2026 Link to item Cite

Improved survival of multiple vs single primary melanomas

Conference JOURNAL OF INVESTIGATIVE DERMATOLOGY · August 2022 Link to item Cite

An Immune Tolerant Sentinel Node Microenvironment Predicts Recurrence in Melanoma

Conference ANNALS OF SURGICAL ONCOLOGY · February 1, 2020 Link to item Cite

Immunogenicity and Optimal Timing of 13-Valent Pneumococcal Conjugate Vaccination during Adjuvant Chemotherapy in Gastric and Colorectal Cancer: A Randomized Controlled Trial.

Conference Cancer research and treatment · January 2020 PurposePneumococcal vaccination (13-valent pneumococcal conjugate vaccine [PCV13]) is recommended to cancer patients undergoing systemic chemotherapy. However, the optimal time interval between vaccine administration and initiation of chemotherapy ... Full text Cite

Nomogram to Predict Survival Benefit of Postoperative Radiotherapy for Major Salivary Gland Cancers

Conference International Journal of Radiation Oncology*Biology*Physics · September 2019 Full text Cite

Perioperative Fresh Red Blood Cell Transfusion May Negatively Affect Recipient Survival After Liver Transplantation.

Conference Ann Surg · February 2018 OBJECTIVE: The aim of this study is to evaluate the association between fresh red blood cell (RBC) transfusion and recipient survival after liver transplantation. BACKGROUND: Fresh RBC products contain many viable leukocytes. Allogeneic leukocytes are resp ... Full text Link to item Cite

LENALIDOMIDE MAINTENANCE VS PLACEBO AFTER STEM CELL TRANSPLANT FOR PATIENTS WITH MULTIPLE MYELOMA: OVERALL SURVIVAL AND PROGRESSION-FREE SURVIVAL AFTER ADJUSTING FOR TREATMENT CROSSOVER IN CALGB

Conference HAEMATOLOGICA · June 26, 2017 Link to item Cite

RESULTS OF US INTERGROUP TRIAL OF RESPONSE-ADAPTED CHEMOTHERAPY OR CHEMOTHERAPY/RADIATION THERAPY BASED ON PET FOR NON-BULKY STAGE I AND II HODGKIN LYMPHOMA (CALGB/ALLIANCE 50604)

Conference HAEMATOLOGICA · October 1, 2016 Link to item Cite

A randomized phase II study of leucovorin, 5-fluorouracil with or without oxaliplatin (LV5FU2 vs. FOLFOX) for curatively-resected, node-positive esophageal squamous cell carcinoma

Conference Annals of Oncology · October 2016 Full text Cite

A Prospective Study Of Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration Compared With MediastINOScopy For Mediastinal Nodal Staging Of Non-Small Cell Lung Cancer

Conference AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE · January 1, 2013 Link to item Cite

GALIXIMAB, AN ANTI-CD80 PRIMATIZED MONOCLONAL ANTIBODY, IN RELAPSED HODGKIN LYMPHOMA (HL): FINAL RESULTS OF CALGB 50602

Conference HAEMATOLOGICA · October 31, 2010 Link to item Cite

Vitamin D receptor (VDR) is over-expressed in the center of uterine fibroids

Conference Fertility and Sterility · September 2010 Full text Cite

Biologic Prognostic Markers in Diffuse Large B-Cell Lymphoma Patients Treated with Dose Adjusted EPOCH-R: a CALGB 50103 Correlative Science Study

Conference BLOOD · November 16, 2008 Link to item Cite

Targeted therapy for in-transit melanoma: Utility of gene expression signatures to define optimal strategy

Conference ANNALS OF SURGICAL ONCOLOGY · February 1, 2007 Link to item Cite

High expression of nucleoside transporter hENT1 predicts a worse event-free survival in relapsed/refractory Hodgkin lymphoma patients treated with gemcitabine, vinorelbine, and liposomal doxorubicin - A CALGB 59804 correlative study.